Demographics (3)
- AGE - Subject age at enrollment (phv00525726.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00525732.v1.p1)
- SEX - Biological sex (phv00525720.v1.p1)
Disease Events (3)
- AFFECTION_STATUS - Case control status of the subject for metastatic melanoma; all subjects are metastatic melanoma patients. (phv00525724.v1.p1)
- TREATMENT_RESPONSE - Clincal response to therapy or tumor treatment (phv00525877.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00525733.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00525725.v1.p1)
Other (11)
- ANALYTE_TYPE - Analyte Type (phv00525729.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525728.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525719.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00525731.v1.p1)
- IS_TUMOR - Tumor status (phv00525730.v1.p1)
- SAMPLE_ID - Sample ID (phv00525727.v1.p1)
- SAMPLE_ID - Sample ID (phv00525722.v1.p1)
- SUBJECT_ID - Subject ID (phv00525723.v1.p1)
- SUBJECT_ID - Subject ID (phv00525718.v1.p1)
- SUBJECT_ID - Subject ID (phv00525721.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00525734.v1.p1)